Jonas Abrahamsson

8.5k total citations
180 papers, 4.4k citations indexed

About

Jonas Abrahamsson is a scholar working on Public Health, Environmental and Occupational Health, Hematology and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Jonas Abrahamsson has authored 180 papers receiving a total of 4.4k indexed citations (citations by other indexed papers that have themselves been cited), including 98 papers in Public Health, Environmental and Occupational Health, 91 papers in Hematology and 51 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Jonas Abrahamsson's work include Acute Lymphoblastic Leukemia research (95 papers), Acute Myeloid Leukemia Research (71 papers) and Childhood Cancer Survivors' Quality of Life (46 papers). Jonas Abrahamsson is often cited by papers focused on Acute Lymphoblastic Leukemia research (95 papers), Acute Myeloid Leukemia Research (71 papers) and Childhood Cancer Survivors' Quality of Life (46 papers). Jonas Abrahamsson collaborates with scholars based in Sweden, Denmark and Finland. Jonas Abrahamsson's co-authors include Erik Forestier, Henrik Hasle, Lotta Mellander, Bernward Zeller, Kjeld Schmiegelow, Mats Heyman, Ólafur G. Jónsson, Josefine Palle, Goda Vaitkevičienė and Kirsi Jahnukainen and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Nature Communications and Journal of Clinical Oncology.

In The Last Decade

Jonas Abrahamsson

172 papers receiving 4.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Jonas Abrahamsson Sweden	39	1.9k	1.8k	1.1k	1.1k	888	180	4.4k
Mats Heyman Sweden	39	2.6k 1.3×	1.3k 0.7×	1.9k 1.7×	1.3k 1.1×	984 1.1×	152	4.6k
James H. Feusner United States	39	1.4k 0.7×	2.5k 1.4×	954 0.8×	2.7k 2.4×	1.3k 1.4×	149	6.1k
James A. Whitlock United States	39	1.8k 0.9×	1.0k 0.6×	1.3k 1.1×	867 0.8×	1.2k 1.4×	141	5.1k
Carmelo Rizzari Italy	34	2.1k 1.1×	1.6k 0.9×	1.4k 1.2×	851 0.7×	572 0.6×	140	3.9k
Gritta Janka‐Schaub Germany	33	2.1k 1.1×	2.1k 1.2×	1.1k 0.9×	1.1k 0.9×	737 0.8×	66	5.1k
Sally E. Kinsey United Kingdom	35	2.0k 1.0×	1.5k 0.8×	1.4k 1.2×	876 0.8×	982 1.1×	116	5.1k
Craig A. Hurwitz United States	31	1.4k 0.7×	1.1k 0.6×	1.2k 1.0×	626 0.5×	847 1.0×	64	3.6k
Joseph Brandwein Canada	40	1.2k 0.6×	2.7k 1.5×	646 0.6×	1.8k 1.5×	1.8k 2.0×	191	5.3k
Nobuko Hijiya United States	33	1.6k 0.8×	1.3k 0.7×	1.1k 0.9×	742 0.6×	623 0.7×	116	3.3k
CR Pinkerton United Kingdom	38	1.1k 0.5×	751 0.4×	939 0.8×	999 0.9×	1.5k 1.7×	157	5.2k

Countries citing papers authored by Jonas Abrahamsson

Since Specialization

Citations

This map shows the geographic impact of Jonas Abrahamsson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jonas Abrahamsson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jonas Abrahamsson more than expected).

Fields of papers citing papers by Jonas Abrahamsson

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jonas Abrahamsson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jonas Abrahamsson. The network helps show where Jonas Abrahamsson may publish in the future.

Co-authorship network of co-authors of Jonas Abrahamsson

This figure shows the co-authorship network connecting the top 25 collaborators of Jonas Abrahamsson. A scholar is included among the top collaborators of Jonas Abrahamsson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jonas Abrahamsson. Jonas Abrahamsson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Harila‐Saari, Arja, Susanna Ranta, Hartmut Vogt, et al.. (2025). Infectious Complications During Early Treatment of Childhood Acute Lymphoblastic Leukemia—A Comparison Between the ALLTogether and NOPHO ALL‐2008 Protocols. Pediatric Blood & Cancer. 73(1). e32120–e32120.

Herlin, Morten Krogh, Jonas Abrahamsson, Nira Arad‐Cohen, et al.. (2024). Comparison of the WHO and ICC Classifications of Cytogenetic Abnormalities in Childhood Acute Myeloid Leukemia. Blood. 144(Supplement 1). 322–322. 1 indexed citations

Tierens, Anne, Liv Osnes, Sanna Siitonen, et al.. (2024). Presence of Leukemia-Related Basophils and Mast Cells with Atypical Immunophenotype during Induction Should Not be Interpreted As Measurable Residual Disease in Children with Acute Myeloid Leukemia with RUNX1::RUNX1T1. Blood. 144(Supplement 1). 2954–2954.

Tierens, Anne, Nira Arad‐Cohen, Daniel KL Cheuk, et al.. (2024). Mitoxantrone Versus Liposomal Daunorubicin in Induction of Pediatric AML With Risk Stratification Based on Flow Cytometry Measurement of Residual Disease. Journal of Clinical Oncology. 42(18). 2174–2185. 16 indexed citations

Östlund, Anders, Anna Staffas, Helene Sjögren, et al.. (2024). Characterization of Pediatric Acute Myeloid Leukemia With t(7;12)(q36;p13). Genes Chromosomes and Cancer. 63(11). e70003–e70003. 1 indexed citations

Tregnago, Claudia, Rhonda E. Ries, Todd A. Alonzo, et al.. (2024). Influence of Nucleophosmin ( NPM1 ) Genotypes on Outcome of Patients With AML: An AIEOP-BFM and COG-SWOG Intergroup Collaboration. Journal of Clinical Oncology. 43(8). 972–984. 1 indexed citations

Kaspers, Gertjan J.L., Jonas Abrahamsson, Nira Arad‐Cohen, et al.. (2022). Clinical outcomes of second relapsed and refractory first relapsed paediatric AML: A retrospective study within the NOPHO‐DB SHIP consortium. British Journal of Haematology. 197(6). 755–765. 9 indexed citations

Nilsson, Tina, Anders Östlund, Susann Li, et al.. (2022). An induced pluripotent stem cell t(7;12)(q36;p13) acute myeloid leukemia model shows high expression of MNX1 and a block in differentiation of the erythroid and megakaryocytic lineages. International Journal of Cancer. 151(5). 770–782. 11 indexed citations

Merli, Pietro, Christiane Walter, Claudia Tregnago, et al.. (2022). Molecular Measurable Residual Disease Assessment before Hematopoietic Stem Cell Transplantation in Pediatric Acute Myeloid Leukemia Patients: A Retrospective Study by the I-BFM Study Group. Biomedicines. 10(7). 1530–1530. 4 indexed citations

10.

Palle, Josefine, Christofer Bäcklin, Jonas Abrahamsson, et al.. (2021). DNA Methylation Signatures Predict Cytogenetic Subtype and Outcome in Pediatric Acute Myeloid Leukemia (AML). Genes. 12(6). 895–895. 9 indexed citations

11.

Sun, Jitong, Aron Skaftason, Markus Mayrhofer, et al.. (2021). Transcriptomic analysis reveals proinflammatory signatures associated with acute myeloid leukemia progression. Blood Advances. 6(1). 152–164. 19 indexed citations

12.

Wolthers, Benjamin Ole, P. Mogensen, Thomas Leth Frandsen, et al.. (2018). Insulin‐dependent diabetes: A chronic complication to acute pancreatitis in childhood acute lymphoblastic leukemia. Pediatric Blood & Cancer. 66(1). e27437–e27437. 9 indexed citations

13.

Pereira, Mariana Buongermino, Jonas Abrahamsson, Tore Samuelsson, et al.. (2018). Accurate and Sensitive Analysis of Minimal Residual Disease in Acute Myeloid Leukemia Using Deep Sequencing of Single Nucleotide Variations. Journal of Molecular Diagnostics. 21(1). 149–162. 13 indexed citations

14.

Norén‐Nyström, Ulrika, Jonas Abrahamsson, Sy Ha, et al.. (2018). Acute myeloid leukemia (AML) with t(7;12)(q36;p13) is associated with infancy and trisomy 19: Data from Nordic Society for Pediatric Hematology and Oncology (NOPHO‐AML) and review of the literature. Genes Chromosomes and Cancer. 57(7). 359–365. 22 indexed citations

15.

Larsson, Fredrik, Anders Åhlin, Mats Heyman, & Jonas Abrahamsson. (2016). [Acute splenic sequestration in children with sickle cell disease--an overview].. PubMed. 113. 2 indexed citations

16.

Toft, N., Henrik Birgens, Jonas Abrahamsson, et al.. (2016). Adults And Children (1-45 Years) With Ph-Negative All Have Almost Identical Outcome In Risk-Stratified Analysis Of Nopho All2008. Haematologica. 101. 35–35. 5 indexed citations

17.

Levinsen, Mette, Hanne Vibeke Marquart, Line Groth‐Pedersen, et al.. (2016). Leukemic blasts are present at low levels in spinal fluid in one‐third of childhood acute lymphoblastic leukemia cases. Pediatric Blood & Cancer. 63(11). 1935–1942. 29 indexed citations

18.

Martinsson, Tommy, Therése Eriksson, Jonas Abrahamsson, et al.. (2010). Appearance of the Novel Activating F1174S ALK Mutation in Neuroblastoma Correlates with Aggressive Tumor Progression and Unresponsiveness to Therapy. Cancer Research. 71(1). 98–105. 59 indexed citations

19.

Abrahamsson, Jonas, B. Carlsson, & Lotta Mellander. (1999). Serum antibody levels and avidities toEscherichia coli O antigens and poliovirus type 1 antigen are increased in children treated for malignant disease. Medical and Pediatric Oncology. 32(6). 416–420. 3 indexed citations

20.

Knudsen, Kai & Jonas Abrahamsson. (1993). Effects of Epinephrine and Norepinephrine on Hemodynamic Parameters and Arrhythmias During a Continuous Infusion of Amitriptyline in Rats. Journal of Toxicology Clinical Toxicology. 31(3). 461–471. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact